People with Medicare drug coverage will pay no more than $2,400 out of pocket for covered Part D drugs in 2027, up from $2,100 in 2026, according to a Nov. 11, 2026, report from Cure Today. The change affects everyone with Part D coverage, whether through a standalone drug plan or a Medicare Advantage plan that includes drug coverage. It matters most for people who take expensive drugs by mouth, such as oral cancer treatments.
How Part D costs change in 2027
The Centers for Medicare & Medicaid Services (CMS) set the 2027 figures in April 2026, the report says.
- The yearly out-of-pocket cap rises $300, from $2,100 to $2,400.
- The highest deductible any drug plan can charge rises from $615 to $700. Some plans have no deductible.
- Once spending on covered Part D drugs reaches $2,400, Medicare says you move into catastrophic coverage and won't pay out of pocket for covered Part D drugs for the rest of the calendar year.
A deductible is the amount you pay before your plan starts sharing the cost.
Who is most affected
According to the report, oral cancer drugs, including targeted therapies and oral chemotherapy, can cost thousands of dollars a month. Many people taking them will reach $2,400 early in the year, sometimes with a single fill, and then pay nothing more for covered Part D drugs until January 2028.
The report contrasts this with the years before the cap existed. In a January 2019 piece, a patient with multiple myeloma said his copays for an oral drug ran about $10,000 per year.
Negotiated prices for four cancer drugs
The report says four cancer drugs will have Medicare-negotiated prices starting Jan. 1, 2027:
- Xtandi (enzalutamide), for prostate cancer
- Pomalyst (pomalidomide), for multiple myeloma and Kaposi sarcoma
- Ibrance (palbociclib), for breast cancer
- Calquence (acalabrutinib), for chronic lymphocytic leukemia and mantle cell lymphoma
The $2,400 cap remains the most anyone pays in a year for covered Part D drugs.
Spreading costs over the year
Hitting the cap in January can still mean a large bill at once. The Medicare Prescription Payment Plan lets you pay Part D drug costs in monthly bills from your plan rather than all at the pharmacy. Medicare says you pay the same total for the year either way.
The report gives this example using the 2027 cap:
- Without the payment plan, a first January fill that reaches $2,400 is paid at the pharmacy that month.
- If you join before that January fill, your plan bills $200 a month for 12 months.
- If you join in July with the same $2,400 due, it is spread over the six remaining months, or $400 a month.
That is why Medicare says people with high drug costs early in the year benefit most. Other details from the report:
- For 2027, Medicare says your plan will automatically renew your participation each year unless you opt out or change plans.
- If you switch plans during open enrollment, you need to sign up again with the new plan.
- People who get or qualify for Extra Help, a program that lowers drug costs for people with limited income, may not be good candidates for the payment plan, according to Medicare.
- Premiums are billed separately and are not part of the payment plan.
What the cap does not include
The cap applies only to covered Part D drugs. It does not include:
- Your monthly premium.
- Drugs covered by Part B, such as chemotherapy infusions given in a doctor's office, clinic or hospital outpatient department. For those, Medicare says you generally pay 20% of the Medicare-approved amount after the Part B deductible.
- Drugs not on your plan's formulary, its list of covered drugs. These won't count toward the cap.
Premiums and plan details to check
CMS set the 2027 base beneficiary premium, a national figure used to calculate plan premiums, at $41.33 a month, the report says. Your actual premium depends on the plan. CMS is also ending, after 2026, a temporary program that helped hold down premiums for standalone drug plans.
The report suggests comparing 2027 plans on total yearly cost, not only the premium, using Medicare's Plan Finder. For each plan, it suggests confirming:
- Whether your drugs are on the formulary.
- Whether they need prior authorization, meaning plan approval before the drug is covered.
- Which pharmacies are in network, including any specialty pharmacy that would fill your drug.
The report notes that a cancer center financial counselor or your State Health Insurance Assistance Program can help free of charge.
Not affiliated with Medicare or any government agency. Coverage and costs vary by plan and state.
Based on reporting by Cure Today, published November 11, 2026. Confirm details with Medicare.gov or your plan before you act.
